Sahajanand Medical Technologies Limited (NSE:SMT)
India · Delayed Price · Currency is INR 496.85
+3.95 (0.80%)
Nov 11, 2026, 1:40 PM IST
NSE:SMT Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 13,552 | 12,105 | 10,249 | 9,016 | 7,955 | 6,896 |
Other Revenue | -6.02 | - | - | - | - | - |
| 13,546 | 12,105 | 10,249 | 9,016 | 7,955 | 6,896 | |
Revenue Growth | - | 18.11% | 13.67% | 13.33% | 15.37% | 16.83% |
Cost of Revenue | 3,572 | 3,101 | 2,602 | 2,424 | 2,013 | 1,859 |
Gross Profit | 9,974 | 9,004 | 7,647 | 6,592 | 5,943 | 5,037 |
Selling, General & Admin | 3,819 | 3,553 | 2,996 | 2,577 | 2,146 | 1,979 |
Other Operating Expenses | 3,975 | 3,610 | 3,276 | 2,898 | 2,648 | 2,591 |
Operating Expenses | 8,615 | 7,905 | 6,898 | 6,120 | 5,342 | 4,948 |
Operating Income | 1,359 | 1,099 | 749.04 | 471.77 | 600.58 | 89.1 |
Interest Expense | -243.5 | -227.78 | -193.81 | -183.3 | -269.37 | -174.9 |
Interest & Investment Income | 35.49 | 35.49 | 73.87 | 17.88 | 9.05 | 18.46 |
Currency Exchange Gain (Loss) | -126.93 | -126.93 | -81.26 | 5.25 | 23.77 | -66.38 |
Other Non Operating Income (Expenses) | 19.81 | 19.81 | 15.4 | 13.1 | -43.98 | -32.66 |
EBT Excluding Unusual Items | 1,044 | 799.78 | 563.24 | 324.7 | 320.05 | -166.38 |
Gain (Loss) on Sale of Assets | -4.24 | -4.24 | -11.07 | 1.65 | -7.57 | 11.9 |
Other Unusual Items | 7.38 | 7.38 | -144.06 | 4.58 | 0.54 | -149.36 |
Pretax Income | 1,047 | 802.92 | 408.11 | 330.93 | 313.02 | -303.83 |
Income Tax Expense | 327.26 | 112.1 | 156.59 | 404.47 | 193.68 | 184.1 |
Earnings From Continuing Operations | 719.95 | 690.82 | 251.52 | -73.54 | 119.34 | -487.93 |
Minority Interest in Earnings | -21.9 | -37.97 | -47.94 | -54.12 | -38.08 | -19.06 |
Net Income | 698.05 | 652.85 | 203.58 | -127.66 | 81.26 | -506.99 |
Net Income to Common | 698.05 | 652.85 | 203.58 | -127.66 | 81.26 | -506.99 |
Net Income Growth | - | 220.69% | - | - | - | - |
Shares Outstanding (Basic) | 98 | 98 | 97 | 97 | 97 | 90 |
Shares Outstanding (Diluted) | 101 | 101 | 101 | 97 | 100 | 93 |
Shares Change | 3.22% | -0.31% | 3.88% | -2.82% | 7.95% | 4.26% |
EPS (Basic) | 7.12 | 6.67 | 2.09 | -1.31 | 0.84 | -5.65 |
EPS (Diluted) | 6.93 | 6.48 | 2.01 | -1.31 | 0.81 | -5.65 |
EPS Growth | - | 222.39% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 446.25 | 72.07 | 245.26 | -11.74 | 219.92 | -784.13 |
Free Cash Flow Per Share | 4.43 | 0.71 | 2.43 | -0.12 | 2.20 | -8.46 |
Gross Margin | 73.63% | 74.38% | 74.61% | 73.12% | 74.70% | 73.05% |
Operating Margin | 10.03% | 9.08% | 7.31% | 5.23% | 7.55% | 1.29% |
Profit Margin | 5.15% | 5.39% | 1.99% | -1.42% | 1.02% | -7.35% |
Free Cash Flow Margin | 3.29% | 0.60% | 2.39% | -0.13% | 2.76% | -11.37% |
EBITDA | 2,028 | 1,689 | 1,277 | 998.3 | 1,043 | 390.73 |
EBITDA Margin | 14.97% | 13.95% | 12.46% | 11.07% | 13.11% | 5.67% |
D&A For EBITDA | 668.92 | 589.65 | 527.81 | 526.53 | 442.21 | 301.63 |
EBIT | 1,359 | 1,099 | 749.04 | 471.77 | 600.58 | 89.1 |
EBIT Margin | 10.03% | 9.08% | 7.31% | 5.23% | 7.55% | 1.29% |
Effective Tax Rate | 31.25% | 13.96% | 38.37% | 122.22% | 61.88% | - |
Revenue as Reported | 13,628 | 12,187 | 10,360 | 9,086 | 8,033 | 6,868 |
Advertising Expenses | - | 5.66 | 5.4 | 9.81 | 11.51 | 17.37 |